← Leaderboards
Xiaoling Zhang
Boston University Medical Campus
$4,575,258
Attributed
$10,624,930
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2021–25$10M$7.5M$5M$2.5M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,624,930 · 4
By mechanism
R01$6,850,431 · 3
U01$3,774,499 · 1
Top collaborators
- Benjamin L Wolozin11 shared
- Peter C Dedon1 shared
- Julia Tcw1 shared
- Gao Wang1 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Benjamin L Wolozin$31,159,035
- Chunyu Liu$5,730,886
- Inna Afasizheva$4,554,042
- Jessica L Fetterman$1,654,939
- Martin Thunemann$1,178,668
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS Disease Related DementiaMolecularLinkUntranslated RnaFunctional DisorderNerve DegenerationTherapeutic TargetPathologyProteinsCodeMutationAgingRna MetabolismRna SplicingAffectMediatingRna-Binding ProteinsNeuropathologyS DiseaseExhibitsAmyotrophic Lateral SclerosisBiologyElements
Grant awards (12)
FunGen-xQTL: Unraveling the genetic basis of molecular functions in Alzheimer's Disease$3,642,232
R01 · FY2025 · AG
tRNA modifications regulating mitochondrial function and the mitochondrial proteome in AD/ADRD$781,008
R01 · FY2025 · AG · contact PI
The role of N6-methyladenosine modified RNA in Alzheimer's disease$780,961
R01 · FY2025 · AG
Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology$597,829
U01 · FY2025 · AG · contact PI
The role of N6-methyladenosine modified RNA in Alzheimer's disease$783,699
R01 · FY2024 · AG
Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology$610,029
U01 · FY2024 · AG · contact PI
Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology$408,750
U01 · FY2024 · AG · contact PI
The role of N6-methyladenosine modified RNA in Alzheimer's disease$806,543
R01 · FY2023 · AG
Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology$615,144
U01 · FY2023 · AG · contact PI
The role of N6-methyladenosine modified RNA in Alzheimer's disease: Equipment Supplement$55,988
R01 · FY2023 · AG
Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology$769,284
U01 · FY2022 · AG · contact PI
Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology$773,463
U01 · FY2021 · AG · contact PI